AU2023224336A1 - Salicylic acid compositions and uses thereof - Google Patents

Salicylic acid compositions and uses thereof Download PDF

Info

Publication number
AU2023224336A1
AU2023224336A1 AU2023224336A AU2023224336A AU2023224336A1 AU 2023224336 A1 AU2023224336 A1 AU 2023224336A1 AU 2023224336 A AU2023224336 A AU 2023224336A AU 2023224336 A AU2023224336 A AU 2023224336A AU 2023224336 A1 AU2023224336 A1 AU 2023224336A1
Authority
AU
Australia
Prior art keywords
metabolite
salicylic acid
extract
formulation
oenothein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023224336A
Other languages
English (en)
Inventor
Philippe Meuwly
Olivier Potterat
Bruno Schnyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmalp SA
Universitaet Basel
Original Assignee
Pharmalp SA
Universitaet Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmalp SA, Universitaet Basel filed Critical Pharmalp SA
Publication of AU2023224336A1 publication Critical patent/AU2023224336A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2023224336A 2022-02-22 2023-02-22 Salicylic acid compositions and uses thereof Pending AU2023224336A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158048 2022-02-22
EP22158048.3 2022-02-22
PCT/EP2023/054364 WO2023161247A1 (en) 2022-02-22 2023-02-22 Salicylic acid compositions and uses thereof

Publications (1)

Publication Number Publication Date
AU2023224336A1 true AU2023224336A1 (en) 2024-07-25

Family

ID=80447273

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2023224336A Pending AU2023224336A1 (en) 2022-02-22 2023-02-22 Salicylic acid compositions and uses thereof

Country Status (8)

Country Link
US (1) US20250152609A1 (https=)
EP (1) EP4482580A1 (https=)
JP (1) JP2025506335A (https=)
CN (1) CN118871117A (https=)
AU (1) AU2023224336A1 (https=)
CA (1) CA3261158A1 (https=)
MX (1) MX2024009823A (https=)
WO (1) WO2023161247A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123356B2 (en) * 2017-03-09 2021-09-21 Epilobium, Inc. Methods of use for oenothein A and B from Epilobium species
US11400102B2 (en) * 2019-05-23 2022-08-02 Washington University Treatment for bacterial infections with salicylic acid analogs

Also Published As

Publication number Publication date
CN118871117A (zh) 2024-10-29
CA3261158A1 (en) 2023-08-31
US20250152609A1 (en) 2025-05-15
EP4482580A1 (en) 2025-01-01
MX2024009823A (es) 2024-08-20
JP2025506335A (ja) 2025-03-11
WO2023161247A1 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
US20110082070A1 (en) Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency
US20120058210A1 (en) Extract of fraxinus excelsior seeds and therapeutic applications therefor
US6979471B1 (en) Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
US20250152609A1 (en) Salicylic acid compositions and uses thereof
Obuotor et al. Antimicrobial activity of Sida acuta, Phyllanthus amarus and Phyllanthus muellerianus against microorganisms implicated in urinary tract infections
KR101179966B1 (ko) 항염증 효과를 갖는 관절염 치료를 위한 약제학적 조성물
Tchoumba Tchoumi et al. Antimicrobial and antidiarrhoeal activities of aqueous and methanolic extracts of Mangifera indica Linn stem bark (Anarcadiaceae) in Wistar rats: LMT Tchoumi et al.
KR20180106103A (ko) 우엉 추출물을 포함하는 항염증성 및 염증성 신경퇴행성 질환 예방 또는 치료용 조성물
Williams et al. Antidiarrhoeal effects of the root extracts of Guiera senegalensis in male mice
Dubey Isolation and studies on chemotherapeutic potential of aloin
WO2025087289A1 (en) New glycoside compound and preparation process thereof
CN103889431B (zh) 开联番木鳖苷酸、包含其的药物组合物及其用途
WO2002017939A1 (en) A composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from glycyrrhiza glabra
KR20180109156A (ko) 모과 추출물을 포함하는 항염증성 및 염증성 신경퇴행성 질환 예방 또는 치료용 조성물
Rashid et al. A PROMISING ANTIDIARRHOEAL, ANTIMICROBIAL AND ANTHELMINTIC EFFECT OF METHANOLIC EXTRACT OF HYGRORYZA ARISTATA LEAVES
WO2007042902A2 (en) Extracts from nyctanthes arbortristis for the treatement of leishmaniasis
KR101122116B1 (ko) 경옥고를 함유하는 아토피 피부염 예방 또는 치료용 조성물
US20130108717A1 (en) Compositions for the treatment of gynaecological disorders
JP2012140336A (ja) ヒトβディフェンシン２産生促進剤
Magaji et al. Phytochemical Composition and Antibacterial Efficacy of Aqueous Leaf Extracts of Guiera senegalensis Against Selected Clinical Isolates
POTHURAJU ANIMAL BIOCHEMISTRY
HK1191281B (en) Extract of fraxinus excelsior seeds and therapeutic applications therefor
HK1147223B (en) Therapeutic applications of extracts of fraxinus excelsior seeds
NZ622493B2 (en) Method for producing dry extracts
KR20090048063A (ko) 나노에멀젼을 유효성분으로 포함하는 치주질환의 치료용조성물